US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam Pharmaceuticals, Inc. | $303.00 | 0.6% | $40.43B | 130.0 | 301.4% | — | Healthcare | 12.3% | 82.6% | ||
| 2 | Ionis Pharmaceuticals, Inc. | $76.85 | 2.1% | $12.7B | -32.3 | 30.1% | — | Healthcare | 141.2% | 47.5% | ||
| 3 | Arrowhead Pharmaceuticals, Inc. | $79.14 | 5.6% | $11.08B | -6486.9 | 129.7% | — | Healthcare | 505% | 43539.2% | ||
| 4 | CRISPR Therapeutics AG | $55.08 | 5.2% | $5.31B | -8.5 | -37.6% | — | Healthcare | 66.1% | -88.9% | ||
| 5 | Beam Therapeutics Inc. | $32.33 | 11.9% | $3.32B | -39.9 | 77.9% | — | Healthcare | 102.2% | 120% | ||
| 6 | Avidity Biosciences, Inc. | $13.09 | 1.4% | $1.98B | -2.6 | -71.4% | — | Healthcare | -50.2% | 72.1% | ||
| 7 | Stoke Therapeutics, Inc. | $33.28 | 1% | $1.96B | -277.3 | 91.7% | — | Healthcare | 280.3% | 404.5% | ||
| 8 | Intellia Therapeutics, Inc. | $13.85 | 4.1% | $1.61B | -3.6 | 27.4% | — | Healthcare | 91% | -100% | ||
| 9 | Wave Life Sciences Ltd. | $7.29 | 1.5% | $1.4B | -6.0 | -26.2% | — | Healthcare | 13.7% | -31.6% | ||
| 10 | Design Therapeutics, Inc. | $14.55 | 8.5% | $909M | -11.9 | -21.2% | — | Healthcare | 300.8% | — | ||
| 11 | Arbutus Biopharma Corporation | $4.42 | 0.5% | $851M | -26.0 | 55% | — | Healthcare | 33.1% | 128.2% | ||
| 12 | Prime Medicine, Inc. | $3.41 | 0.6% | $616M | -2.5 | 18.5% | — | Healthcare | 156.4% | 55.3% | ||
| 13 | Silence Therapeutics plc | $7.36 | 3.1% | $348M | -3.9 | -161.7% | — | Healthcare | 96.3% | -98.7% | ||
| 14 | Editas Medicine, Inc. | $3.18 | 4.4% | $311M | -1.8 | 37.5% | — | Healthcare | 138.7% | -100% | ||
| 15 | Arcturus Therapeutics Holdings Inc. | $9.13 | 8.6% | $260M | -3.8 | 20.3% | — | Healthcare | -18.8% | -46.4% | ||
| 16 | CAMP4 Therapeutics Corporation | $4.06 | 2% | $190M | -1.5 | 48% | — | Healthcare | 75% | — | ||
| 17 | ProQR Therapeutics N.V. | $1.72 | 5.5% | $181M | -4.3 | -45.9% | — | Healthcare | 10.3% | -13% | ||
| 18 | PepGen Inc. | $1.85 | -4.4% | $127M | -0.9 | 15.1% | — | Healthcare | 43% | — | ||
| 19 | Korro Bio, Inc. | $13.34 | 6% | $125M | -1.1 | -32.9% | — | Healthcare | -9.9% | 181.5% | ||
| 20 | Precision BioSciences, Inc. | $7.52 | 0.9% | $96M | -2.1 | -57% | — | Healthcare | 47.5% | -11.9% | ||
| 21 | Metagenomi, Inc. Common Stock | $1.43 | 1.4% | $54M | -0.6 | -21.2% | — | Healthcare | -1.4% | -43.9% | ||
| 22 | Aligos Therapeutics, Inc. | $6.37 | 0.3% | $39M | -2.6 | 51.1% | — | Healthcare | 39.1% | -44.6% | ||
| 23 | Sangamo Therapeutics, Inc. | $0.18 | 31.6% | $38M | -0.4 | 41.3% | — | Healthcare | -71% | -37.1% | ||
| 24 | Exicure, Inc. | $3.39 | -0.3% | $22M | -2.1 | -209.2% | — | Healthcare | -67.7% | -100% | ||
| 25 | Phio Pharmaceuticals Corp. | $1.15 | 1.8% | $7M | -0.8 | -294107.8% | — | Healthcare | -33.1% | — | ||
| 26 | TransCode Therapeutics, Inc. | $7.52 | -4.3% | $6M | -0.2 | -647.4% | — | Healthcare | -25.8% | — | ||
| 27 | Silexion Therapeutics Ltd. | $0.57 | -5.1% | $2M | -0.1 | 309.5% | — | Healthcare | -96.1% | — | ||
| 28 | Silexion Therapeutics Ltd. | $0.02 | -3.8% | $47212 | -0.0 | 61.6% | — | Healthcare | -78.3% | — |
Showing 28 stocks